» Articles » PMID: 23785335

BDNF and Schizophrenia: from Neurodevelopment to Neuronal Plasticity, Learning, and Memory

Overview
Specialty Psychiatry
Date 2013 Jun 21
PMID 23785335
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-Derived Neurotrophic Factor (BDNF) is a neurotrophin that has been related not only to neurodevelopment and neuroprotection, but also to synapse regulation, learning, and memory. Research focused on the neurobiology of schizophrenia has emphasized the relevance of neurodevelopmental and neurotoxicity-related elements in the pathogenesis of this disease. Research focused on the clinical features of schizophrenia in the past decades has emphasized the relevance of cognitive deficits of this illness, considered a core manifestation and an important predictor for functional outcome. Variations in neurotrophins such as BDNF may have a role as part of the molecular mechanisms underlying these processes, from the neurodevelopmental alterations to the molecular mechanisms of cognitive dysfunction in schizophrenia patients.

Citing Articles

Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review.

Motamedi-Manesh A, Asanjan M, Fallah H, Gharibian S, Taghavi A, Poode Z Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39976721 DOI: 10.1007/s00210-025-03912-7.


BDNF methylation associated with stress in women: Novel insights in epigenetics and inflammation.

Fungaro Rissatti L, Wilson D, Palace-Berl F, de Mello Ponteciano B, Sardela de Miranda F, Alece Arantes Moreno I Brain Behav Immun Health. 2024; 42:100900.

PMID: 39552782 PMC: 11565430. DOI: 10.1016/j.bbih.2024.100900.


Efficacy of Horticultural Therapy on Positive, Negative, and Affective Symptoms in Individuals with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Lee Y, Chen T, Hsu C, Chen M, Lin P, Huang Y Healthcare (Basel). 2024; 12(21).

PMID: 39517317 PMC: 11545822. DOI: 10.3390/healthcare12212104.


Unraveling the socio-cognitive consequences of KCC2 disruption in zebrafish: implications for neurodevelopmental disorders and therapeutic interventions.

Naderi M, Nguyen T, Pompili C, Kwong R Front Mol Neurosci. 2024; 17:1483238.

PMID: 39469188 PMC: 11513385. DOI: 10.3389/fnmol.2024.1483238.


Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review.

Liberona A, Jones N, Zuniga K, Garrido V, Zelada M, Silva H Int J Mol Sci. 2024; 25(20).

PMID: 39456983 PMC: 11508575. DOI: 10.3390/ijms252011204.


References
1.
Jockers-Scherubl M, Danker-Hopfe H, Mahlberg R, Selig F, Rentzsch J, Schurer F . Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett. 2004; 371(1):79-83. DOI: 10.1016/j.neulet.2004.08.045. View

2.
Hohn A, Leibrock J, Bailey K, Barde Y . Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990; 344(6264):339-41. DOI: 10.1038/344339a0. View

3.
Takahashi M, Kakita A, Futamura T, Watanabe Y, Mizuno M, Sakimura K . Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment. J Neurochem. 2006; 99(3):770-80. DOI: 10.1111/j.1471-4159.2006.04106.x. View

4.
Dempster E, Toulopoulou T, McDonald C, Bramon E, Walshe M, Filbey F . Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet. 2005; 134B(1):73-5. DOI: 10.1002/ajmg.b.30150. View

5.
Murray R, Lappin J, Di Forti M . Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol. 2008; 18 Suppl 3:S129-34. DOI: 10.1016/j.euroneuro.2008.04.002. View